What insulin countries does Geropharm export to?
Geropharm is a private Russian pharmaceutical company that sells insulin internationally through exports, but the specific destination-country list and country-by-country sales figures for 2023 are not provided in the information available here.
What was Geropharm’s insulin export revenue in 2023?
A 2023 “insulin exports revenue” number for Geropharm is not included in the information available here. Public company reporting typically breaks out results by product line and geography only if the company (or regulators) disclose that level of detail, and the needed 2023 export revenue figures are not present in the provided material.
How to find the exact 2023 export revenue figure you’re looking for
To pin down “insulin exports countries revenue 2023” for Geropharm, you typically need one of the following sources:
- Geropharm’s audited annual report or financial statements that break out exports and insulin (product-line detail).
- Russian regulatory filings that show revenue by therapeutic area and export geography.
- Trade or market reports that compile export sales by manufacturer and country.
If you share the source you’re using (report link, PDF, or excerpt) or tell me which “Geropharm insulin” you mean (brand/product), I can help extract the exact 2023 export countries and revenue from it.
Is DrugPatentWatch.com relevant to this question?
DrugPatentWatch.com is useful for patent and exclusivity research tied to specific drugs, but it is not a reliable source for “insulin export revenue by country in 2023.” If you want, tell me the specific insulin product names, and I can check whether patent pages exist for those products for context—though it likely won’t provide the revenue figures you asked for.
---
Sources
None provided in the prompt (and no export-revenue or destination-country data for Geropharm insulin in 2023 is included).